Low expression of CD40L in tumor-free lymph node of oral cavity cancer related with poor prognosis

Yoon Chan Rah, Jae Cheul Ahn, Eun Hui Jeon, Hyojin Kim, Jin Ho Paik, Woo Jin Jeong, Soon Young Kwon, Soon Hyun Ahn

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: Recently, the genetic alterations associated with tumor progression and impaired host immunity against transformed cells draw increased attention. Here, we characterized the differential gene expression patterns and protein expression in tumor-free lymph node from recurrent and non-recurrent tumors to identify independent prognostic markers for oral squamous cell carcinoma (OSCC). Methods: A cDNA microarray analysis was performed to identify the differentially expressed genes in regional tumor-free lymph nodes from OSCC patients with and without recurrence. Then, the protein expression of the selected genes was analyzed by immunohistochemistry in 60 OSCC patients to determine their association with survival. Results: Widespread down-regulation of genes involved in antigen processing and recognition in lymph nodes was a distinctive feature. In univariate Kaplan–Meier analysis, lower expression of CD40L and CD80 in tumor-free lymph nodes was significantly correlated with poorer survival. In multivariate Cox regression analysis, CD40L was identified as an independent prognostic marker of disease-free survival. Conclusion: Our data indicate that impaired host immunity (decreased CD40L expression) along with the TNM staging might be an important factor determining the prognosis of OSCC.

Original languageEnglish
Pages (from-to)1-9
Number of pages9
JournalInternational Journal of Clinical Oncology
DOIs
Publication statusAccepted/In press - 2018 May 14

Fingerprint

CD40 Ligand
Mouth Neoplasms
Mouth
Lymph Nodes
Squamous Cell Carcinoma
Neoplasms
Immunity
Gene Expression
Survival
Neoplasm Staging
Antigen Presentation
Microarray Analysis
Oligonucleotide Array Sequence Analysis
Genes
Disease-Free Survival
Proteins
Down-Regulation
Immunohistochemistry
Regression Analysis
Recurrence

Keywords

  • CD40L
  • Lymph node
  • Oral squamous cell carcinoma

ASJC Scopus subject areas

  • Surgery
  • Hematology
  • Oncology

Cite this

Low expression of CD40L in tumor-free lymph node of oral cavity cancer related with poor prognosis. / Rah, Yoon Chan; Ahn, Jae Cheul; Jeon, Eun Hui; Kim, Hyojin; Paik, Jin Ho; Jeong, Woo Jin; Kwon, Soon Young; Ahn, Soon Hyun.

In: International Journal of Clinical Oncology, 14.05.2018, p. 1-9.

Research output: Contribution to journalArticle

Rah, Yoon Chan ; Ahn, Jae Cheul ; Jeon, Eun Hui ; Kim, Hyojin ; Paik, Jin Ho ; Jeong, Woo Jin ; Kwon, Soon Young ; Ahn, Soon Hyun. / Low expression of CD40L in tumor-free lymph node of oral cavity cancer related with poor prognosis. In: International Journal of Clinical Oncology. 2018 ; pp. 1-9.
@article{f8b8755c0bcc495ca494a690b05793c7,
title = "Low expression of CD40L in tumor-free lymph node of oral cavity cancer related with poor prognosis",
abstract = "Background: Recently, the genetic alterations associated with tumor progression and impaired host immunity against transformed cells draw increased attention. Here, we characterized the differential gene expression patterns and protein expression in tumor-free lymph node from recurrent and non-recurrent tumors to identify independent prognostic markers for oral squamous cell carcinoma (OSCC). Methods: A cDNA microarray analysis was performed to identify the differentially expressed genes in regional tumor-free lymph nodes from OSCC patients with and without recurrence. Then, the protein expression of the selected genes was analyzed by immunohistochemistry in 60 OSCC patients to determine their association with survival. Results: Widespread down-regulation of genes involved in antigen processing and recognition in lymph nodes was a distinctive feature. In univariate Kaplan–Meier analysis, lower expression of CD40L and CD80 in tumor-free lymph nodes was significantly correlated with poorer survival. In multivariate Cox regression analysis, CD40L was identified as an independent prognostic marker of disease-free survival. Conclusion: Our data indicate that impaired host immunity (decreased CD40L expression) along with the TNM staging might be an important factor determining the prognosis of OSCC.",
keywords = "CD40L, Lymph node, Oral squamous cell carcinoma",
author = "Rah, {Yoon Chan} and Ahn, {Jae Cheul} and Jeon, {Eun Hui} and Hyojin Kim and Paik, {Jin Ho} and Jeong, {Woo Jin} and Kwon, {Soon Young} and Ahn, {Soon Hyun}",
year = "2018",
month = "5",
day = "14",
doi = "10.1007/s10147-018-1294-3",
language = "English",
pages = "1--9",
journal = "International Journal of Clinical Oncology",
issn = "1341-9625",
publisher = "Springer Japan",

}

TY - JOUR

T1 - Low expression of CD40L in tumor-free lymph node of oral cavity cancer related with poor prognosis

AU - Rah, Yoon Chan

AU - Ahn, Jae Cheul

AU - Jeon, Eun Hui

AU - Kim, Hyojin

AU - Paik, Jin Ho

AU - Jeong, Woo Jin

AU - Kwon, Soon Young

AU - Ahn, Soon Hyun

PY - 2018/5/14

Y1 - 2018/5/14

N2 - Background: Recently, the genetic alterations associated with tumor progression and impaired host immunity against transformed cells draw increased attention. Here, we characterized the differential gene expression patterns and protein expression in tumor-free lymph node from recurrent and non-recurrent tumors to identify independent prognostic markers for oral squamous cell carcinoma (OSCC). Methods: A cDNA microarray analysis was performed to identify the differentially expressed genes in regional tumor-free lymph nodes from OSCC patients with and without recurrence. Then, the protein expression of the selected genes was analyzed by immunohistochemistry in 60 OSCC patients to determine their association with survival. Results: Widespread down-regulation of genes involved in antigen processing and recognition in lymph nodes was a distinctive feature. In univariate Kaplan–Meier analysis, lower expression of CD40L and CD80 in tumor-free lymph nodes was significantly correlated with poorer survival. In multivariate Cox regression analysis, CD40L was identified as an independent prognostic marker of disease-free survival. Conclusion: Our data indicate that impaired host immunity (decreased CD40L expression) along with the TNM staging might be an important factor determining the prognosis of OSCC.

AB - Background: Recently, the genetic alterations associated with tumor progression and impaired host immunity against transformed cells draw increased attention. Here, we characterized the differential gene expression patterns and protein expression in tumor-free lymph node from recurrent and non-recurrent tumors to identify independent prognostic markers for oral squamous cell carcinoma (OSCC). Methods: A cDNA microarray analysis was performed to identify the differentially expressed genes in regional tumor-free lymph nodes from OSCC patients with and without recurrence. Then, the protein expression of the selected genes was analyzed by immunohistochemistry in 60 OSCC patients to determine their association with survival. Results: Widespread down-regulation of genes involved in antigen processing and recognition in lymph nodes was a distinctive feature. In univariate Kaplan–Meier analysis, lower expression of CD40L and CD80 in tumor-free lymph nodes was significantly correlated with poorer survival. In multivariate Cox regression analysis, CD40L was identified as an independent prognostic marker of disease-free survival. Conclusion: Our data indicate that impaired host immunity (decreased CD40L expression) along with the TNM staging might be an important factor determining the prognosis of OSCC.

KW - CD40L

KW - Lymph node

KW - Oral squamous cell carcinoma

UR - http://www.scopus.com/inward/record.url?scp=85046907279&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85046907279&partnerID=8YFLogxK

U2 - 10.1007/s10147-018-1294-3

DO - 10.1007/s10147-018-1294-3

M3 - Article

C2 - 29761306

AN - SCOPUS:85046907279

SP - 1

EP - 9

JO - International Journal of Clinical Oncology

JF - International Journal of Clinical Oncology

SN - 1341-9625

ER -